FDA Drug Recalls

Recalls / Class II

Class IID-0389-2016

Product

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills (Racepinephrine USP 11.25 mg), 30 individual foil wrapped vials per carton, Manufactured By: nephron pharmaceuticals corporation, Orlando, FL --- NDC 0487-2784-01

Affected lot / code info
Lots R4016A (Exp 08/31/2015), R4017A (Exp 08/31/2015), R4035A (Exp 12/31/2015)

Why it was recalled

Discoloration

Recalling firm

Firm
Nephron Pharmaceuticals Corp.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
4121 SW 34th St, Orlando, Florida 32811-6475

Distribution

Quantity
32,490 cartons
Distribution pattern
Nationwide

Timeline

Recall initiated
2015-08-21
FDA classified
2015-11-27
Posted by FDA
2015-12-09
Terminated
2017-02-10
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0389-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls